1.Prof.Panjing gave an oral presentation on the theme of"DONOR-DERIVED CD5 CAR-T CELLS FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA"

2.Prof.Liu Shuangyou made a poster display with the theme of"THE TREATMENT RESPONSE OF A TWO-DOSE REGIMEN OF DOSE-ADJUSTED INOTUZUMAB IN RELAPSED/REFRACTORY B-ALL"

3.Dr.Zheng Peihao made a poster display with the theme of"DURABLE REMISSION AFTER SEQUENTIAL CD19/20 CAR-T-CELL“CAKE-ICING”THERAPY OCCURRED IN REFRACTORY/RELAPSED DLBCL"

4.Prof.Yangfan made a poster display with the theme of"EARLY ADMINISTRATION OF POLATUZUMAB VEDOTIN AS BRIDGING CD19-SPECIFIC CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY IS AN EFFECTIVE STRATEGY TO IMPROVE SURVIVAL IN PATIENTS WITH R/R B-CELL LYMPHOMA"

5.Dr.Guo Yuelu made a poster display with the theme of"A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY.IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA"

6.Prof.Zhenq Qinlong made a poster display with the theme of"IMPACT OF ARID1A AND TP53 MUTATIONS IN PEDIATRIC REFRACTORY OR RELAPSED MATURE B-CELL LYMPHOMA TREATED WITH CAR-T CELL THERAPY"

7.Dr.Liu Zhanxiang made a poster display with the theme of"SALVAGE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS ALSO THE CURATIVE AND SAFE TREATMENT FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA IN THE ERA OF TARGETED THERAPY"

8.Dr.Lin Yuehui was selected as the abstract of the paper on the topic"OBSERVATION OF THERAPEUTIC EFFECT OF BLINATUMOMAB SALVAGE TREATMENT ON B-ALL WITH INVALID OR RECURRENT CAR-T"

9.Dr.Guo Yuelu was selected as the abstract of the paper on the topic"A PROSPECTIVE INVESTIGATION INTO THE TIMING AND STATUS OF BCMA-CAR-T IN SECONDARY PLASMA CELL LEUKEMIA"

10.Dr.Su Guoai was selected as the abstract of the paper on the topic"OUTCOMES OF ANTI-CANCER THERAPY IN PATIENTS WITH PROGRESSIVE REFRACTORY/RELAPSED B-CELL LYMPHOMA DURING SEVERE CORONAVIRUS DISEASE 2019(COVID-19):A REAL-WORLD STUDY FROM CHINA"

11.Dr.Liu Rui was selected as the abstract of the paper on the topic"CAR-T CELL THERAPY IS A EXCELLENT STRATEGY FOR R/R B-NHL"

12.Prof.Li Zhihui was selected as the abstract of the paper on the topic"THE RISK FACTORS ON THE SEVERITY OF SARS-COV2 OMICRON VARIANT INFECTION IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES AFTER ALLOGENEIC HEMATOPOIEITC STEM CELL TRANSPLANTATION"